Central venous illness in hemodialysis sufferers

Results from the Dialysis Outcomes and Practice Patterns Study
April 7, 2021 0 Comments

Kidney Res Clin Pract. 2019 Sep; 38(3): 309–317.

,1,2 and corresponding author2


Central venous illness (CVD) is troublesome to deal with and sometimes proof against remedy. In CVD, hemodialysis vascular entry ought to generally be deserted, or in severe instances, the affected person’s life could also be threatened. Due to this fact, prevention is good. Nonetheless, because the prevalence of persistent kidney illness (CKD) has elevated steadily with inhabitants getting old, CKD sufferers with a peripherally inserted central catheter (PICC) are encountered often. PICCs could cause CVD, and the basilic vein, which is considered the necessary final possibility for native arteriovenous fistula (AVF) creation in end-stage renal illness (ESRD) sufferers, is destroyed often after its use because the entry website of PICC. Essentially the most well-established danger components for CVD are a historical past of central venous catheter (CVC) insertion and its length of use. Due to this fact, to cut back the incidence of CVD, catheterization within the central vein (CV) ought to be minimized, together with its length of use. On this assessment, we are going to first clarify the fundamental territories of the CV and introduce its pathophysiology, scientific options, and superior remedy choices. Lastly, we are going to emphasize prevention of CVD.

Key phrases: Central venous illness, Persistent kidney illness, Hemodialysis, Prevention


Central venous illness (CVD) represents a pathological situation during which stenosis or occlusion happens within the central vein (CV) [1]. The well-known reason behind CVD is the presence of historical past of central venous catheter (CVC) insertion. As using peripherally inserted central catheter (PICC) has been quickly rising lately, extra consideration ought to be paid to CVD. Though superior vena cava (SVC) syndrome might be brought on by a tumor invading the mediastinum, there’s typically no symptom in non-hemodialysis (HD) sufferers with CVD and restricted venous blood stream quantity [2]. Nonetheless, in end-stage renal illness (ESRD) sufferers with HD, as a result of a big blood stream quantity of vascular entry (VA) finally passes by means of the CV, CVD typically manifests as edema. Research on remedy of symptomatic CVD have been most typical in HD sufferers [3,4]. CVD sufferers might not be good candidates for surgical procedure as a result of lesion presence within the thorax, and such sufferers usually tend to have a number of co-morbidities [5]. Endovascular intervention, particularly using stent-grafts (SG), appears promising, however prevention of CVD is most necessary.

In scientific observe, because the prevalence of persistent kidney illness (CKD) has been rising steadily because the inhabitants ages, CKD sufferers from different departments who’re utilizing PICC are encountered often [6]. PICC could cause CVD, and the basilic vein, which is the necessary final possibility for native arteriovenous fistula (AVF) creation in ESRD sufferers, is destroyed often after its use because the entry website of PICC [7]. Due to this fact, the aim of this assessment is to introduce pointers to stop CVD for non-nephrology physicians. All supplies for radiologic and photographic figures on this article have been authorized by the Institutional Evaluation Board (IRB) of St. Vincent’s Hospital, The Catholic College of Korea (IRB No. VC19RESE0062). Facial exposures have been very restricted to ensure anonymity.

Anatomy and pathophysiology

The central venous system contains the superior and inferior vena cava and proper and left brachiocephalic, subclavian, inner jugular, and iliac veins. Nonetheless, it doesn’t embody axillary, femoral, or exterior jugular veins (). CVD might be divided into instances related to earlier catheter insertion and people not related to earlier catheter insertion [8,9].

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f1.jpg

Anatomy of the venous system displaying central veins along with the veins of the proximal a part of higher and decrease extremities.

Circumstances related to earlier catheter insertion typically expertise stenosis or occlusion. Essentially the most well-known danger issue related to CVD is length of catheter insertion. The longer is the interval of insertion within the vein, the higher is the likelihood of central venous stenosis or occlusion. There are stories that variety of catheter insertions and dimension of the catheter are additionally associated, however no agency conclusions have been established [10].

In instances not related to earlier catheter insertion, turbulent VA blood stream damages the vessel wall and causes stenosis of the CV. Left brachiocephalic vein (BCV) stenosis is an efficient instance of this phenomenon. In left BCV, stenosis normally happens at two factors, the junction of the left subclavian vein (SCV) and inner jugular vein (IJV) and the junction of the left BCV with the correct BCV extending to the SVC. Moreover, the left BCV is situated between the sternum and pulsating aorta, which additionally contributes to stenosis. For related anatomical causes, a catheter inserted into the left IJV, in distinction to the correct IJV, ought to be bent and can typically contact the vessel wall on the two locations talked about above alongside its path to the correct atrium (RA) (). Such catheter contact damages the vessel wall and causes stenosis.

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f2.jpg

Proper-side inserted catheter into the correct inner jugular vein (IJV) with a straight path (A) and left-side inserted catheter into left IJV with a number of curves (B).

Additionally, as a result of the SCV is situated between the clavicle and the primary rib, catheter insertion into the SCV causes frequent stenosis, which is why the IJV is used because the entry website for long-term HD catheter insertion.

Medical manifestations

Medical options might differ in line with lesion location, however the nearer the lesion is to the RA, the extra extreme is the scientific function. The most typical scientific manifestation of CVD in HD sufferers is arm edema ().

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f3.jpg

Left brachiocephalic vein (BCV) stenosis.

Left BCV stenosis documented in angiography induced ipsilateral arm swelling in contrast with the normal-sized proper arm in a hemodialysis affected person.

Though SCV catheterization for HD is prohibited, SCV stenosis can happen after diagnostic angiography as a result of edema of the arm. In such instances, stenoses are sometimes noticed on the junction of the SCV and the IJV, leading to turbulent venous blood stream. In some instances, that is identified as a type of thoracic outlet syndrome (TOS) when the SCV is compressed between the clavicle and the primary rib.

Stenosis or occlusion of 1 BCV manifests as ipsilateral arm and facial edema (, ), however swelling of the face or arm might not be apparent if collateral veins are plentiful.

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f4.jpg

Proper brachiocephalic vein (BCV) stenosis.

Facial swelling (A) manifested on this affected person, which was brought on by hemodialysis (HD) catheter insertion into the stenosed proper BCV documented in angiography (B). It resolved with HD catheter elimination (C) and subsequent percutaneous transluminal angioplasty on proper BCV after arteriovenous fistula maturation (D).

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f5.jpg

Superior vena cava (SVC) syndrome.

Facial swelling manifested (A) after left-side inserted hemodialysis (HD) catheter insertion into the stenosed SVC, confirmed in chest computed tomography (B). It resolved with HD catheter elimination (C).

The presence of collateral veins is a crucial issue affecting consciousness of the scientific manifestations of CVD (). These collateral veins embody intercostal, azygos, hemiazygos, and accent hemiazygos veins. In instances of plentiful collateral stream to the intercostal veins, ipsilateral breast swelling might be the manifestation of CVD.

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f6.jpg

Asymptomatic central vein illness.

A number of collateral veins with diffuse stenosis in the correct subclavian vein and full occlusion in the correct brachiocephalic vein visualized in angiography in a hemodialysis affected person with no grievance about arm swelling.


Issues associated to HD VA have an effect on the survival price of ESRD sufferers. Varied methods of endovascular remedy resulted in a breakthrough growth within the remedy of HD VA [11–13]. Nonetheless, the lesion of CV is far much less attentive to endovascular remedy than that of a peripheral location. However, endovascular remedy is most well-liked in CVD due to the surgical limitation as a result of lesion presence within the thorax, and ESRD sufferers are older and often have a number of comorbidities [14].

Percutaneous transluminal angioplasty (PTA) with balloon dilatation is the first foundation for endovascular remedy. Nonetheless, balloon dilation ought to be carried out provided that there’s a scientific indication equivalent to arm or face swelling. A number of research have reported that balloon dilation for a narrowed lesion discovered by the way on angiogram and with out signs accelerates lesion progress [15–17].

If signs are current, PTA is carried out; nonetheless, patency is poor, so repeat procedures are sometimes required. Due to this fact, in lots of instances, the stent or SG is inserted later [18]. As a result of the diameter of the CV is bigger than that of the peripheral vein, balloon dilatation might not effectively dilate and proper the lesion. Current research utilizing intravascular ultrasound (IVUS) for CVD confirmed that, though the lesion was sufficiently enlarged on angiography after PTA, IVUS demonstrated inadequate dilation or extrusion by the balloon catheter [19]. In such instances, extra PTA utilizing a bigger balloon catheter might be thought of, however the danger of vessel rupture may additionally improve, requiring consideration to the potential of CV rupture. Though stent use within the venous system is anticipated to have end result, as in instances of coronary or peripheral arteries, quite a few research confirmed failure of stent use, particularly in HD VA, due to neointimal hyperplasia (NIH) inside the stent, resulting in a decrease patency price than that of PTA [20,21]. Nonetheless, stent or SG use in full CV occlusion might be thought of as a guiding position for subsequent procedures if recanalization is achieved. The SG is a construction that applies graft materials to the within or outdoors of the stent to create a bodily barrier to NIH. SG use appears promising in CVD as a result of it has been constantly reported to have a greater patency price than stent alone or PTA [20,22–24]. Particularly, in CVD, SG use confirmed favorable patency in contrast with PTA in a number of retrospective research, though no potential research have been printed but. exhibits a abstract of the research on SG use in HD CVD [3,18,22,25,26].

Desk 1

Abstract of major and first assisted patencies of SG in HD VA research

Research Sort of SG Variety of sufferers Main/major assisted patencies (%)

6 mo 12 mo 24 mo
Kundu et al [25] Fluency 14 100/NA NAa/NA NA/NA
Anaya-Ayala et al [22] Viabahnb 25 NA/NA 56/86 NA/NA
Jones et al [3] Viabahn 30 81/100 67/80 45/75
Verstandig et al [26] Viabahn & Fluencyb 52 60/96 40/94 28/85
Quaretti et al [18] Variedc 20 100/NA 100/NA 84/NA

Nonetheless, SG use has limitations in that edge stenosis can develop at both finish, rising medical prices. As a result of the SG is inserted the place two veins meet, one vein might be blocked, and the corresponding vein can’t be used to create a brand new AVF; thus, consideration ought to be paid when inserting a SG in such a location ().

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f7.jpg

Jailing vs. with out jailing.

Proper inner jugular vein (IJV) was jailed by Naked steel stent (a 10-mm-diameter×100-mm-long Wall-stent Endoprosthesis; Boston Scientific, Marlborough, MA, USA) placement in the correct subclavian vein in order that it can’t be accessible for the additional catheter insertion (A). Stent-graft (a 12-mm-diameter×60-mm-long Hercules Vascular; S&G Biotech, Yongin, Korea) was efficiently deployed on the left brachiocephalic vein (BCV) stenosis with out jailing of the correct BCV in a symptomatic hemodialysis affected person with left arm swelling (B).

As in coronary and peripheral artery illnesses, using drug-coated balloon (DCB) in HD VA has been studied extensively and confirmed some advantages. Nonetheless, most of these research excluded CVD due to the absence of a large-diameter DCB. There are solely two research of DCB use in CVD [27,28], every of which demonstrated advantages. Nonetheless, within the meta-analysis of those two research, the profit was not noticed. Based mostly on private experiences in CVD intervention, an elastic recoil phenomenon is often famous, and it has been prompt that inadequate luminal achieve is achieved by PTA based mostly on IVUS [19,29]. Due to this fact, the advantage of DCB in CVD appears restricted.

Surgical choices for CVD might be divided into three classes: influx discount, uncommon bypass together with reconstruction surgical procedure and claviculectomy, or first rib resection in TOS [30].

There are some research about influx discount together with HD sufferers with excessive output cardiac standing, however just one examine targeted on influx discount in HD sufferers with CVD [31]. Influx might be lowered by non-surgical banding or varied surgical methods together with plication, graft banding or wrapping, and graft interposition. Improvement of CVD might be defined by inflow-outflow mismatch, indicating the significance of influx discount. Nonetheless, to maximise its efficacy, influx quantity ought to be sufficiently lowered. For this, intraoperative quantity measurement utilizing duplex ultrasound ought to be carried out throughout quantity discount [32,33].

Uncommon bypass surgical procedures embody easy bypass utilizing a graft to the ipsilateral jugular vein or bypass to the contralateral jugular, axillary, or femoral vein in a decrease extremity. Moreover, direct connection to the SVC or RA might be carried out, however such surgical procedures should not easy and confer danger and problems. Subtle surgical choices might be actively thought of in non-elderly sufferers with out comorbidities or when SG is unavailable. Nonetheless, in scientific observe, HD sufferers are getting older and often have a number of comorbidities such that danger vs. advantages for surgical choices ought to be mentioned with the affected person and a vascular surgeon. A multidisciplinary strategy is necessary and required, particularly in CVD.

Closure of a corresponding HD VA is the best and most dependable surgical possibility. Nonetheless, it’s not straightforward to find out this, as a result of HD VA is a lifeline in these sufferers, and there are restricted out there veins within the human physique ().

An external file that holds a picture, illustration, etc.
Object name is krcp-38-309f8.jpg

Therapy stream diagram in CVD.

AVF, arteriovenous fistula; BMS, naked steel stent; CVD, central vein illness; PTA, percutaneous transluminal angioplasty; Qac, vascular entry stream quantity; TOS, thoracic outlet syndrome; VA, vascular entry.


Throughout surgical procedure for CVD, VA generally ought to be deserted to keep away from life-threatening problems. Due to this fact, the simplest methodology is CVD prevention. Though the Kidney Illness Outcomes High quality Initiative (KDOQI) pointers counsel venous preservation for native AVF creation to start at CKD stage 4 [34], the American Society of Diagnostic and Interventional Nephrology (ASDIN) and Affiliation of Vascular Entry (AVA) advocate that venous preservation begin at CKD stage 3 [35]. For related causes, use of PICC is prohibited beginning in CKD stage 3. CKD stage is assessed in line with estimated glomerular filtration price (eGFR), which is routinely calculated by means of a formulation such because the Modification of Weight loss program in Renal Illness (MDRD) equation utilizing parameters together with serum creatinine, age, intercourse, and race. Nonetheless, as a result of serum creatinine stage is extra acquainted to non-nephrology physicians than eGFR, serum creatinine 2.0 mg/dL or greater is really useful as a typical for venous preservation, and PICC use ought to be prohibited non-nephrology physicians. For subclavian catheterization, the identical rule might be utilized. Though it’s effectively acknowledged amongst nephrologists that subclavian catheterization shouldn’t be carried out in CKD sufferers, it nonetheless happens often. Due to this fact, non-nephrology physicians ought to be instructed to keep away from this process.


Varied remedy choices are at the moment being tried for CVD, however all have limitations. Due to this fact, prevention is good. First, catheterization ought to be minimized in CV, as its efficiency is a widely known reason behind CVD. It’s also necessary to reduce the length of CVC use. Lastly, use of the correct IJV with a straight path ought to at all times be thought of somewhat than the left IJV with curvature. As well as, remedy of CV lesions might speed up its development, and remedy have to be carried out with care.


Conflicts of curiosity

All authors don’t have any conflicts of curiosity to declare.

Authors’ contributions

Hoon Suk Park and Joonsung Choi conceived of the offered concept. Hoon Suk Park wrote the macuscript. Jun Hyun Baik supervised this venture. All authors mentioned the findings and contributed to the ultimate model of manuscript.


1. Agarwal AK. Central vein stenosis. Am J Kidney Dis. 2013;61:1001–1015. doi: 10.1053/j.ajkd.2012.10.024. [PubMed] [CrossRef] [Google Scholar]
2. Agarwal AK, Khabiri H, Haddad NJ. Problems of vascular entry: superior vena cava syndrome. Am J Kidney Dis. 2017;69:309–313. doi: 10.1053/j.ajkd.2016.08.040. [PubMed] [CrossRef] [Google Scholar]
3. Jones RG, Willis AP, Jones C, McCafferty IJ, Riley PL. Lengthy-term outcomes of stent-graft placement to deal with central venous stenosis and occlusion in hemodialysis sufferers with arteriovenous fistulas. J Vasc Interv Radiol. 2011;22:1240–1245. doi: 10.1016/j.jvir.2011.06.002. [PubMed] [CrossRef] [Google Scholar]
4. Falk A, Maya ID, Yevzlin AS RESCUE Investigators. A potential, randomized examine of an expanded polytetrafluoroethylene stent graft versus balloon angioplasty for instent restenosis in arteriovenous grafts and fistulae: two-year outcomes of the RESCUE examine. J Vasc Interv Radiol. 2016;27:1465–1476. doi: 10.1016/j.jvir.2016.06.014. [PubMed] [CrossRef] [Google Scholar]
5. Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J. Present traits of dialysis remedy in Korea: 2015 registry knowledge specializing in aged sufferers. Kidney Res Clin Pract. 2016;35:204–211. doi: 10.1016/j.krcp.2016.09.006. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. El Ters M, Schears GJ, Taler SJ, et al. Affiliation between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control examine in hemodialysis sufferers. Am J Kidney Dis. 2012;60:601–608. doi: 10.1053/j.ajkd.2012.05.007. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. McGill RL, Ruthazer R, Meyer KB, Miskulin DC, Weiner DE. Peripherally inserted central catheters and hemodialysis outcomes. Clin J Am Soc Nephrol. 2016;11:1434–1440. doi: 10.2215/CJN.01980216. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologist’s perspective. Semin Dial. 2007;20:53–62. doi: 10.1111/j.1525-139X.2007.00242.x. [PubMed] [CrossRef] [Google Scholar]
9. Kundu S. Central venous illness in hemodialysis sufferers: prevalence, etiology and remedy. J Vasc Entry. 2010;11:1–7. doi: 10.1177/112972981001100101. [PubMed] [CrossRef] [Google Scholar]
10. Chick JF, Reddy SN, Yam BL, Kobrin S, Trerotola SO. Establishment of a hospital-based central venous entry coverage for peripheral vein preservation in sufferers with persistent kidney illness: a 12-year expertise. J Vasc Interv Radiol. 2017;28:392–397. doi: 10.1016/j.jvir.2016.11.007. [PubMed] [CrossRef] [Google Scholar]
11. Park HS, Lee YH, Kim HW, et al. Usefulness of assisted procedures for arteriovenous fistula maturation with out compromising entry patency. Hemodial Int. 2017;21:335–342. doi: 10.1111/hdi.12499. [PubMed] [CrossRef] [Google Scholar]
12. Cho S. The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist. Kidney Res Clin Pract. 2017;36:175–181. doi: 10.23876/j.krcp.2017.36.2.175. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Cho S, Lee YJ, Kim SR. Medical expertise with ultrasound guided angioplasty for vascular entry. Kidney Res Clin Pract. 2017;36:79–85. doi: 10.23876/j.krcp.2017.36.1.79. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Jin DC, Yun SR, Lee SW, et al. Present traits of dialysis remedy in Korea: 2016 registry knowledge specializing in diabetic sufferers. Kidney Res Clin Pract. 2018;37:20–29. doi: 10.23876/j.krcp.2018.37.1.20. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Levit RD, Cohen RM, Kwak A, et al. Asymptomatic central venous stenosis in hemodialysis sufferers. Radiology. 2006;238:1051–1056. doi: 10.1148/radiol.2383050119. [PubMed] [CrossRef] [Google Scholar]
16. Ehrie JM, Sammarco TE, Chittams JL, Trerotola SO. Unmasking of beforehand asymptomatic central venous stenosis following percutaneous transluminal angioplasty of hemodialysis entry. J Vasc Interv Radiol. 2017;28:1409–1414. doi: 10.1016/j.jvir.2017.07.006. [PubMed] [CrossRef] [Google Scholar]
17. Yan Y, Sudheendra D, Dagli MS, et al. Impact of central venous angioplasty on hemodialysis entry circuit stream: potential examine of 25 symptomatic sufferers. J Vasc Interv Radiol. 2015;26:984–991. doi: 10.1016/j.jvir.2015.03.005. [PubMed] [CrossRef] [Google Scholar]
18. Quaretti P, Galli F, Moramarco LP, et al. Stent grafts offered superior major patency for central venous stenosis remedy as compared with angioplasty and naked steel stent: a retrospective single heart examine on 70 hemodialysis sufferers. Vasc Endovascular Surg. 2016;50:221–230. doi: 10.1177/1538574416639149. [PubMed] [CrossRef] [Google Scholar]
19. de Graaf R, van Laanen J, Peppelenbosch N, van Loon M, Tordoir J. The worth of intravascular ultrasound within the remedy of central venous obstructions in hemodialysis sufferers. J Vasc Entry. 2016;17(Suppl 1):S12–S15. doi: 10.5301/jva.5000536. [PubMed] [CrossRef] [Google Scholar]
20. Haskal ZJ, Trerotola S, Dolmatch B, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362:494–503. doi: 10.1056/NEJMoa0902045. [PubMed] [CrossRef] [Google Scholar]
21. Salman L, Asif A. Stent graft for nephrologists: considerations and consensus. Clin J Am Soc Nephrol. 2010;5:1347–1352. doi: 10.2215/CJN.02380310. [PubMed] [CrossRef] [Google Scholar]
22. Anaya-Ayala JE, Smolock CJ, Colvard BD, et al. Efficacy of lined stent placement for central venous occlusive illness in hemodialysis sufferers. J Vasc Surg. 2011;54:754–759. doi: 10.1016/j.jvs.2011.03.260. [PubMed] [CrossRef] [Google Scholar]
24. Patel D, Ray CE, Jr, Lokken RP, Bui JT, Lipnik AJ, Gaba RC. Superior stent graft remedy of venous stenosis affecting hemodialysis vascular entry: case illustrations. Semin Intervent Radiol. 2016;33:39–45. doi: 10.1055/s-0036-1572550. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
25. Kundu S, Modabber M, You JM, Tam P, Nagai G, Ting R. Use of PTFE stent grafts for hemodialysis-related central venous occlusions: intermediate-term outcomes. Cardiovasc Intervent Radiol. 2011;34:949–957. doi: 10.1007/s00270-010-0019-4. [PubMed] [CrossRef] [Google Scholar]
26. Verstandig AG, Berelowitz D, Zaghal I, et al. Stent grafts for central venous occlusive illness in sufferers with ipsilateral hemodialysis entry. J Vasc Interv Radiol. 2013;24:1280–1287. doi: 10.1016/j.jvir.2013.04.016. [PubMed] [CrossRef] [Google Scholar]
27. Kitrou PM, Papadimatos P, Spiliopoulos S, et al. Paclitaxel-coated balloons for the remedy of symptomatic central venous stenosis in dialysis entry: outcomes from a randomized managed trial. J Vasc Interv Radiol. 2017;28:811–817. doi: 10.1016/j.jvir.2017.03.007. [PubMed] [CrossRef] [Google Scholar]
28. Massmann A, Fries P, Obst-Gleditsch Ok, Minko P, Shayesteh-Kheslat R, Buecker A. Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in sufferers with hemodialysis fistulas. J Endovasc Ther. 2015;22:74–79. doi: 10.1177/1526602814566907. [PubMed] [CrossRef] [Google Scholar]
29. Ross JR, Franga DL, Gallichio M, Patel AJ, Ouriel Ok. Function of intravascular ultrasound imaging throughout endovascular interventions of failing hemodialysis entry grafts. J Vasc Surg. 2017;65:1383–1389. doi: 10.1016/j.jvs.2016.10.115. [PubMed] [CrossRef] [Google Scholar]
30. Anaya-Ayala JE, Bellows PH, Ismail N, et al. Surgical administration of hemodialysis-related central venous occlusive illness: a remedy algorithm. Ann Vasc Surg. 2011;25:108–119. doi: 10.1016/j.avsg.2010.11.002. [PubMed] [CrossRef] [Google Scholar]
31. Jennings WC, Miller GA, Coburn MZ, Howard CA, Lawless MA. Vascular entry stream discount for arteriovenous fistula salvage in symptomatic sufferers with central venous occlusion. J Vasc Entry. 2012;13:157–162. doi: 10.5301/jva.5000020. [PubMed] [CrossRef] [Google Scholar]
32. Zanow J, Petzold Ok, Petzold M, Krueger U, Scholz H. Move discount in high-flow arteriovenous entry utilizing intraoperative stream monitoring. J Vasc Surg. 2006;44:1273–1278. doi: 10.1016/j.jvs.2006.08.010. [PubMed] [CrossRef] [Google Scholar]
33. Tellioglu G, Berber I, Kilicoglu G, Seymen P, Kara M, Titiz I. Doppler ultrasonography-guided surgical procedure for high-flow hemodialysis vascular entry: preliminary outcomes. Transplant Proc. 2008;40:87–89. doi: 10.1016/j.transproceed.2007.11.059. [PubMed] [CrossRef] [Google Scholar]
34. Vascular Entry 2006 Work Group. Medical Apply Tips for Vascular Entry. Am J Kidney Dis. 2006;48(Suppl 1):S176–S247. doi: 10.1053/j.ajkd.2006.04.029. [PubMed] [CrossRef] [Google Scholar]
35. Hoggard J, Saad T, Schon D, Vesely TM, Royer T American Society of Diagnostic and Interventional Nephrology, Medical Apply Committee; Affiliation for Vascular Entry. Tips for venous entry in sufferers with persistent kidney illness. A Place Assertion from the American Society of Diagnostic and Interventional Nephrology, Medical Apply Committee and the Affiliation for Vascular Entry. Semin Dial. 2008;21:186–191. doi: 10.1111/j.1525-139X.2008.00421.x. [PubMed] [CrossRef] [Google Scholar]

Leave a Reply

Your email address will not be published. Required fields are marked *